US · DMAAR
Drugs Made In America Acquisition Corp. Rights
- Sector
- Financial Services · Shell Companies
- Headquarters
- Fort Lauderdale, FL 33301
- Website
- dmaacorp.com
Price · as of 2024-12-31
$0.08
Market cap 1.84M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
AI valuation
Our deep-learning model estimates Drugs Made In America Acquisition Corp. Rights's (DMAAR) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $0.08
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| DMAAR | Drugs Made In America Acq… | $0.08 | 1.84M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | -2.71 | — | 6.27 | 1.70 | — | — | — | — | — | -0.37 | — | — | 0.00% | — | — | — | — | — |
| ATMV | AlphaVest Acquisition Cor… | $10.30 | 38.24M | — | — | — | — | 26.00 | 2.73 | — | 26.66 | 55.47 | 2.73 | 0.00% | — | — | 5.12% | -1.86% | 4.96% | 0.07 | — | 0.00 | 0.00 | 0.66 | 4687.00% | — | -10486.00% | 0.07% | 0.02 | 0.09% | 0.00% | 0.00% | 80.83% | -52.38 | 1487.95 | — | 14.81 |
| RELI | Reliance Global Group, In… | $0.29 | 1.26M | +32,390% | +93% | — | — | -0.16 | 0.47 | 0.10 | -2.47 | — | -0.15 | 18.77% | -54.75% | -64.55% | -178.85% | -42.73% | -44.99% | 4.35 | -4.86 | 1.12 | 0.53 | -2.22 | -1193.00% | 235.00% | 15038.00% | -184.72% | -0.70 | -14.43% | 0.00% | 0.00% | 39.14% | -1.83 | -5.41 | 1.00 | -4.45 |
| SCAG | Scage Future American Dep… | $1.73 | 125.61M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | 0.56 | — | 0.00 | 0.00 | -13.41 | — | — | — | — | -0.17 | — | — | 0.00% | — | — | — | — | — |
| TAVIR | Tavia Acquisition Corp. | $0.21 | 3.42M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | 0.00 | — | 1.21 | 1.16 | -5.20 | — | — | — | — | -0.09 | — | — | 0.00% | — | — | — | — | — |
About Drugs Made In America Acquisition Corp. Rights
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
- CEO
- Lynn Stockwell
- Employees
- 0
- Beta
- 3.19
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.08) − 1 = — (DCF, example).